These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5218380)

  • 1. Enhancement of protection against staphylococcal infection by vaccines.
    Kenney M; Illes CH
    N Y State J Med; 1966 May; 66(9):1084-7. PubMed ID: 5218380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation of delayed-action staphylococcal vaccine. I. Effect of the vaccine on local skin infection in rabbits].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):77-85. PubMed ID: 6492938
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on experimental mastitis in goats: staphylococcal infection in the mammary glands of experimental goats and a protection test with formalized staphylococcal vaccine.
    Fujikura T
    Natl Inst Anim Health Q (Tokyo); 1966; 6(1):1-7. PubMed ID: 6006055
    [No Abstract]   [Full Text] [Related]  

  • 4. Staphylococcus vaccines.
    Greenberg L
    Bull N Y Acad Med; 1968 Oct; 44(10):1222-6. PubMed ID: 5245432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of staphylococcal infection with special reference to the preventive effect on "infection death" on mice pretreated with live or chrome-killed vaccine of various staphylococcal strains].
    Abe M
    Nihon Saikingaku Zasshi; 1966 Mar; (3):125-32. PubMed ID: 6005851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation of delayed-action staphylococcal vaccine. II. Effect of the vaccine on the course of generalized infection in mice].
    Giedrys-Galant S; Hałasa J; Podkowińska I
    Med Dosw Mikrobiol; 1984; 36(2):87-91. PubMed ID: 6492939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in the prevention of staphylococcal infection in a maternity home].
    Zuĭkova AI; Mikhaĭlova MV; Zheltukhin EN; Astapova AP; Dubrovskaia NA; Zhizhina AP; Rizaeva NA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):87-8. PubMed ID: 5720154
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study on the prevention of the cavity formation. (The prevention of cavity formation by staphylococci)].
    Yamagata H; Ogawa Y; Nishi K; Abo J
    Arerugi; 1966 Jan; 15(1):37-47. PubMed ID: 5959746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoprophylaxis of staphylococcal diseases pregnant women and newborn infants].
    Ivanov L; Apostolov G; Pekhlivanov K; Mitev B
    Akush Ginekol (Sofiia); 1971; 10(16):482-6. PubMed ID: 5147136
    [No Abstract]   [Full Text] [Related]  

  • 10. [A study of the efficacy of immunization of pregnant women with staphylococcal toxoid for the prevention of staphylococcal infections in infants].
    Valkovtsy AA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):87. PubMed ID: 5720153
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serological tests as criteria for immunity to staphylococcal skin infection in rabbits.
    Cameron CM
    Onderstepoort J Vet Res; 1971 Jun; 38(2):99-101. PubMed ID: 5162614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of antitoxin formation in pregnant women under the effect of their immunization with adsorbed staphylococcal anatoxin].
    Busigina NG; Starukh RM
    Pediatr Akus Ginekol; 1965; 6():39-42. PubMed ID: 5879185
    [No Abstract]   [Full Text] [Related]  

  • 14. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of antitoxic (antileukocidin) immunity on the development of staphylococcal infection in experimental infection with staphylococcus strains of different toxigenicity].
    Maĭorova GF; Kushko IV; Parchinskaia IA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jan; 49(1):5-9. PubMed ID: 5010281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Draft guidelines for the production, testing and the use of staphylococcal vaccines].
    Thilo W; Dinger E; Rische H; Lüderitz U; Witte W
    Z Gesamte Hyg; 1981 Apr; 27(4):287-90. PubMed ID: 7340234
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specific prevention of pyodermatites of staphylococcal etiology in workers of metal industry].
    Levina AA; Mar GI
    Vestn Dermatol Venerol; 1966 Sep; 40(9):20-2. PubMed ID: 4232089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specificity of the complement-fixation test for toxoplasmosis in staphylococcal infections].
    Eremeeva EA
    Med Parazitol (Mosk); 1969; 38(3):314-7. PubMed ID: 5407773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental test of an ointment for surface staphylococcal infections].
    Parodi E; Acanfora D
    G Ig Med Prev; 1968; 9(2):179-85. PubMed ID: 5744724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.